Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Julphar
Baxter
Chubb
Citi
Covington
US Army
McKinsey
Merck

Generated: February 20, 2019

DrugPatentWatch Database Preview

Mcneil Company Profile

« Back to Dashboard

What is the competitive landscape for MCNEIL, and what generic and branded alternatives to MCNEIL drugs are available?

MCNEIL has sixteen approved drugs.



Summary for Mcneil
US Patents:0
Tradenames:9
Ingredients:6
NDAs:16
Patent Litigation for Mcneil: See patent lawsuits for Mcneil

Drugs and US Patents for Mcneil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mcneil METHOCARBAMOL AND ASPIRIN aspirin; methocarbamol TABLET;ORAL 089193-001 Feb 12, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Mcneil MEDIPREN ibuprofen TABLET;ORAL 071215-001 Jun 26, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Mcneil Cons BENADRYL diphenhydramine hydrochloride INJECTABLE;INJECTION 006146-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Mcneil MEDIPREN ibuprofen TABLET;ORAL 070475-001 Feb 6, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Mcneil MOTRIN ibuprofen SUSPENSION/DROPS;ORAL 020476-001 May 25, 1995 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Mcneil Ped MOTRIN ibuprofen TABLET, CHEWABLE;ORAL 020135-002 Nov 16, 1994 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Mcneil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mcneil Cons NICOTROL nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020536-001 Jul 3, 1996 4,915,950 ➤ Try a Free Trial
Mcneil Consumer MOTRIN ibuprofen SUSPENSION;ORAL 019842-001 Sep 19, 1989 5,374,659*PED ➤ Try a Free Trial
Mcneil Ped MOTRIN ibuprofen TABLET, CHEWABLE;ORAL 020135-001 Nov 16, 1994 5,215,755*PED ➤ Try a Free Trial
Mcneil Ped MOTRIN ibuprofen TABLET, CHEWABLE;ORAL 020135-002 Nov 16, 1994 5,215,755*PED ➤ Try a Free Trial
Mcneil Ped MOTRIN ibuprofen TABLET, CHEWABLE;ORAL 020135-002 Nov 16, 1994 5,320,855*PED ➤ Try a Free Trial
Mcneil Ped MOTRIN ibuprofen TABLET, CHEWABLE;ORAL 020135-001 Nov 16, 1994 5,320,855*PED ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Healthtrust
AstraZeneca
Accenture
Federal Trade Commission
QuintilesIMS
Johnson and Johnson
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.